Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Xiromed LLC, priced at $0.1067 per EA under NDC 70700026330. Its NADAC has been published 461 times since Aug 30, 2017.
Strength
30 mg/1
Manufacturer
Xiromed LLCNDC
70700026330
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203203On Market Since
8/24/2018
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 461 times since Aug 30, 2017, and over the history we have for it it has declined 59.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.2616 (Sep 13, 2017) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1104 |
| 52-week low | $0.1049 |
| Median price | $0.1331 |
| Average price | $0.1444 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 461 |
| Tracking since | Aug 30, 2017 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Xiromed LLC, is $0.1067 per EA (NDC 70700026330), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 59.2%. It has been tracked across 461 weekly CMS publications since Aug 30, 2017.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Aug 30, 2017, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.2616 (Sep 13, 2017), with a median of $0.1331 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
9 NADAC-published products share the same active ingredient, strength, and dosage form as LANSOPRAZOLE DR 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 70700026330) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification